Loading organizations...
Wyvern Asset Management Ltd operates as a venture fund manager, deploying capital into early-stage technology companies. The firm manages and raises new funds, identifying nascent technological innovations to foster growth within its portfolio. Its investment approach supports emerging businesses across diverse sectors, focusing on high-potential ventures.
The firm was established in January 2007 by co-founder Andrew J Allars, a seasoned financial professional. Allars founded Wyvern Asset Management Ltd with the insight that targeted venture capital support is essential for scaling promising technology businesses. His extensive finance experience underpins the firm’s investment philosophy.
Wyvern Asset Management Ltd primarily serves limited partners seeking exposure to high-growth technology ventures. The firm's long-term vision centers on impacting the technological landscape by acting as a pivotal capital provider for innovations. It aims to cultivate a robust portfolio that drives industry advancement and generates strong returns.
Wyvern Asset Management has 1 tracked investment across 1 company. The latest tracked deal is $27.0M Series B in Binx Health in July 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2011 | Binx Health | $27.0M Series B | — | Earlybird Venture Capital, EQT Life Sciences, HealthCap, OrbiMed, BB Biotech Ventures, Braveheart Investment Group, Crescent, Johnson & Johnson Innovation, LSP, Novartis, YFM Equity Partners |